The iron-removing effect of Deferasirox dispersible tablets

Delasirox dispersible tablets are an iron chelator, mainly used to treat iron overload caused by multiple blood transfusions. In cases of iron overload, too much free iron accumulates in the body, which may cause damage to important organs such as the heart and liver. The mechanism of action of deferasirox is to combine excess free iron to form a soluble complex, promoting its excretion from the body, thereby reducing the iron burden on tissues and organs.

1. Clinical trial design

In clinical trials of deferasirox dispersible tablets, a double-blind, randomized, placebo-controlled design is usually adopted. Patients were randomly divided into deferasirox and placebo groups to evaluate the effect of deferasirox dispersible tablets on iron removal. The endpoints of clinical trials usually include iron loading levels, serum iron indicators, liver function, etc.

2. Iron removal effect

Study results generally include significant differences in iron removal in the deferasirox-treated group relative to the placebo group. The evaluation of iron removal effect may involve multiple indicators, such as:

Iron load reduction: The degree of reduction in total iron load in the body during the treatment period in the deferasirox treatment group compared to the placebo group.

Serum iron level: The decrease in serum iron level in the deferasirox treatment group compared with the placebo group during the treatment period.

Improvement of liver function: The improvement of liver function indicators in the deferasirox treatment group compared with the placebo group during the treatment period.

Heart and organ protection: The protective effect of deferasirox treatment group on the heart and other organs during the treatment period compared with the placebo group.

3. Application in clinical practice

In actual clinical practice, deferasirox dispersible tablets are often considered an effective iron-reduction treatment option. Doctors usually develop personalized treatment plans based on the patient's specific conditions, such as age, weight, disease severity, etc. Monitoring is the key during treatment, and hematological parameters, liver function, kidney function, etc. are regularly checked to ensure the safety and effectiveness of treatment.

It should be noted that deferasirox dispersible tablets may cause some side effects, such as headache, nausea, vomiting, etc. Patients should pay close attention to any symptoms of discomfort during use and communicate with their doctor in a timely manner. Doctors will adjust treatment plans based on patient feedback and test results to protect the patient's overall health.

Overall, deferasirox dispersible tablets are an important choice in iron removal treatment with good efficacy and safety. However, the specific therapeutic effect needs to be evaluated based on the latest research and clinical trial data. Patients should follow their doctor's recommendations when receiving treatment to ensure the best results.

Dedeferasirox dispersible tablets have been launched in China and have been included in medical insurance. Patients can purchase them domestically. The price of domestic specifications125mg*28 tablets is around 600 to 700. For specific prices and medical insurance reimbursement, please consult the local hospital pharmacy. There are original and generic deferasirox dispersible tablets in foreign countries. The original drug is mainly the Swiss Novartis original drug, and the price of 400mg*30 tablets is around 400 to 500; the generic drugs are mainly Indian generic drugs, and the specification of 400mg*30 tablets is about 300 to 400, and the ingredients of the original drug and generic drugs are basically the same.